There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.